Deep Genomics

Deep Genomics is a biotechnology company that applies deep learning, genomics and automation to discover and develop genetic medicines. Their platform predicts the molecular and cellular effects of genetic variation to identify targets and design therapeutic modalities (such as oligonucleotides and small molecules), accelerating preclinical discovery. By combining predictive AI models with high‑throughput experiments and partnerships with pharma, they aim to improve the speed and success rate of developing treatments for genetic diseases.